Pharmaceuticals News and Research

RSS

Antipodean Pharma commences phase 2 trial in hepatitis C

Antipodean Pharmaceuticals has announced it has initiated a Phase 2 clinical trial of its lead compound MitoQ (mitoquinone) to investigate the drug's efficacy to reduce liver damage in patients with raised liver enzymes associated with the Hepatitis C virus (HCV).

5 Feb 2007

Direct synthesis of polymer nanocapsules with a noncovalently tailorable surface

To accurately transport pharmaceutical agents to their specific target organs or cell types, you need a good carrier: nanoscopic capsules with surface elements that can "recognize" the target in question could do the trick.

5 Feb 2007

Disappointing end to trials of new gel to protect women against AIDS

In what appears to be a disappointing outcome, trials of a new gel designed for women to protect themselves from the AIDS virus were stopped this week when researchers found that women using it became infected at a higher rate than women not using it.

1 Feb 2007

FDA approves Neuren's phase 3 Glypromate trial

Neuren Pharmaceuticals has announced that the US Food and Drug Administration (FDA) has accepted its investigational new drug application (IND) and authorised the Company to proceed with its Phase 3 trial to prevent cognitive impairment following major cardiac surgery using Glypromate.

30 Jan 2007

Novartis' day in court could leave millions without AIDS drugs

The Swiss pharmaceutical giant Novartis is in court in India this week challenging the country's patent laws.

30 Jan 2007

Access Pharmaceuticals issued U.S. patent

This patent, entitled "O,O'-Amidomalonato and N,O-Amidomalonato Platinum Complexes" is one of a series of patents and patent applications owned by Access which provides intellectual property protection to ProLindac and related tumor-targeted platinum compounds.

30 Jan 2007

TV ads for drugs high on the emotions but low on facts

According to a new study television commercials for prescription drugs are heavily loaded on the emotional side but offer scant information on the disease itself and do little to promote the benefits of a healthy lifestyle.

30 Jan 2007

Thailand the latest drug patent buster

Thailand's military government has used World Trade Organization (WTO) rules regarding intellectual property, to allow the sale of generic versions of two important drugs used to treat HIV/AIDS and heart disease.

29 Jan 2007

Guyanese Health Ministry to provide $450,000 for HIV/AIDS programs

The Guyanese Ministry of Health on Tuesday announced it will provide $450,000 to 16 nongovernmental organizations to conduct HIV/AIDS programs nationwide, the Stabroek News reports.

28 Jan 2007

Panel recommends FDA to not create specific effectiveness standard for oral contraceptive approvals

A panel of gynecologists, researchers and other medical experts on Wednesday at the end of a two-day meeting convened by FDA recommended the agency not set a specific standard of effectiveness for approval of oral contraceptives, the AP/Minneapolis Star Tribune reports.

28 Jan 2007

Thailand plans to break antiretroviral patents

Thai Public Health Minister Mongkol Songkhla plans to break patents on an antiretroviral drug and a drug for heart disease by issuing compulsory licenses to produce lower-cost versions, Ministry of Public Health spokesperson Suphan Srithamma announced on Thursday, AFP/Yahoo! News reports.

28 Jan 2007

A plasminogen-activating protease specifically controls the development of primary pneumonic plague

The deadly attack of the bacterium that causes pneumonic plague is significantly slowed when it can't make use of a key protein, scientists at Washington University School of Medicine in St. Louis report in Science.

28 Jan 2007

More med schools, hospitals ban gifts from pharmaceutical companies

An increased number of U.S. medical schools and hospitals have begun to ban meals and other gifts from pharmaceutical companies to physicians, residents and medical students "in response to concerns about whether the pharmaceutical industry's expensive marketing efforts influence which drugs doctors prescribe and whether those costs get passed on to patients.

23 Jan 2007

Access Pharmaceuticals receives MuGard patent allowance

Access Pharmaceuticals, Inc has announced that the Company has received a "Notice of Allowance" letter from the United States Patent and Trademark Office for its patent application entitled "Liquid Formulations for the Prevention and Treatment of Mucosal Diseases and Disorders."

22 Jan 2007

Lessons from Vioxx litigation

The pharmaceutical industry, academia and government agencies need to work together to restore faith in drug development, say doctors in this weeks' British Medical Journal.

18 Jan 2007

New screening process helps better diagnose oral cancers

Patients with early stage oral cancer may benefit from a more advanced screening process allowing for a more accurate diagnosis, according to a study presented at the plenary session at the Multidisciplinary Head and Neck Cancer Symposium in Rancho Mirage, Calif., co-sponsored by the American Society for Therapeutic Radiology and Oncology, the American Society of Clinical Oncology and the American Head and Neck Society.

18 Jan 2007